蓝丰生化：海南闻勤拟减持不超3%股份

Core Viewpoint - Hainan Wenqin intends to reduce its stake in Bluefeng Biochemical by up to 11,267,818 shares, representing a maximum of 3% of the company's total share capital, due to funding needs [1] Group 1: Shareholding and Reduction Plan - Hainan Wenqin currently holds 23,793,411 shares in Bluefeng Biochemical, accounting for 6.3349% of the total share capital [1] - The reduction will occur within three months after the announcement, utilizing both centralized bidding and block trading methods [1] - The maximum shares to be reduced via centralized bidding will not exceed 1% of the total share capital, while block trading will not exceed 2% [1] Group 2: Impact on Company Structure - The reduction plan will not lead to a change in the control of the company, as Hainan Wenqin is not a controlling shareholder or actual controller [1] - There will be no impact on the company's governance structure, equity structure, or ongoing operations as a result of this reduction [1]